Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163408 · ClinicalTrials.gov registry record
3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 134
- Enrollment target
NCT02163408: Completed study, sponsored by Cedars-Sinai Medical Center.
NCT02163408 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 134 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02163408 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
This is a technical development study with the goal to develop 3D techniques for atherosclerosis plaque characterization. We hypothesize that 3D MRI is superior to 2D MRI in characterizing major plaque constituents that contribute to severe clinical events such as myocardial infarction or stroke. The major advantages of the 3D techniques to be developed will include high spatial resolution, reduced scan times, and optimized image contrast. The use of contrast injection is not needed with the new techniques, which is greatly beneficial for patients with advanced chronic kidney disease.This is not a funded clinical trial.
Primary Outcome
Images collected from both investigational MRI pulse sequences and conventional protocol will be reviewed and scored by readers and compared.
Interventions
- OTHER MRI with/without contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2014-06-24 |
| Est. Completion | 2022-04-25 |
What the finished NCT02163408 record still lists
NCT02163408 is an observational study that tracks outcomes without assigning an intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI with/without contrast is the first listed.
NCT02163408 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02163408 about?
NCT02163408 is a clinical study titled "3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery". This is a technical development study with the goal to develop 3D techniques for atherosclerosis plaque characterization. We hypothesize that 3D MRI is superior to 2D MRI in characterizing major plaque constituents that contribute to severe clinical events such as myocardial infarction or stroke. Th...
What is the current status of trial NCT02163408?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2014-06-24. Estimated completion is 2022-04-25.
What interventions are being tested in trial NCT02163408?
The interventions under investigation include: MRI with/without contrast (OTHER).
Who is sponsoring clinical trial NCT02163408?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI